PIN4 COST-BENEFIT ANALYSIS OF OSELTAMIVIR VERSUS NO ANTIVIRAL TREATMENT FROM THE EMPLOYER PERSPECTIVE-THE ROCHE BRAZIL CASE
Nov 1, 2007, 00:00
10.1016/S1098-3015(10)65511-8
https://www.valueinhealthjournal.com/article/S1098-3015(10)65511-8/fulltext
Title :
PIN4 COST-BENEFIT ANALYSIS OF OSELTAMIVIR VERSUS NO ANTIVIRAL TREATMENT FROM THE EMPLOYER PERSPECTIVE-THE ROCHE BRAZIL CASE
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)65511-8&doi=10.1016/S1098-3015(10)65511-8
First page :
Section Title :
Open access? :
No
Section Order :
669